How Lilly Is Helping To Address The UK’s ‘Postcode Lottery’ For Cancer Drugs
Some innovative cancer drugs are not reaching eligible patients in the UK, despite securing positive reimbursement opinions from NICE. Eli Lilly explains how industry can be “part of the solution” through partnership initiatives.